Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM Wu, JN Hu, HY Gu, J Hua, J Chen, JR Xu - Breast cancer research and …, 2012 - Springer
Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …
被引用次数：128 相关文章

Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM Wu, JN Hu, HY Gu, J Hua, J Chen… - Breast Cancer Research …, 2012 - europepmc.org
Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …

Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM Wu, JN Hu, HY Gu, J Hua… - … cancer research and …, 2012 - pubmed.ncbi.nlm.nih.gov
Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …

Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

L Wu, J Hu, H Gu, J Hua, J Chen… - Breast Cancer Research …, 2012 - search.proquest.com
Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …

Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM Wu, JN Hu, HY Gu, J Hua, J Chen, JR Xu - Breast Cancer Research …, 2012 - infona.pl
Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …

[引用][C] Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM Wu, JN Hu, HY Gu, J Hua, J Chen… - Breast Cancer Research …, 2012 - hero.epa.gov
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate
and predict pathological response to neoadjuvant chemotherapy in patients with breast …
[HTML] nih.gov

[HTML][HTML] Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy …

LM Wu, JN Hu, HY Gu, J Hua, J Chen… - Database of Abstracts of …, 2012 - ncbi.nlm.nih.gov
This review concluded that diffusion-weighted magnetic resonance imaging (MRI) was
highly sensitive and contrast-enhanced MRI was highly specific for predicting the …

[引用][C] Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM WU, JN HU, HY GU, JIA HUA… - … cancer research and …, 2012 - pascal-francis.inist.fr
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate
and predict pathological response to neoadjuvant chemotherapy in patients with breast …

[引用][C] Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM Wu, JN Hu, HY Gu, J Hua, J Chen, JR Xu - Breast Cancer Research and … - Springer

[引用][C] Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM WU, JN HU, HY GU, JIA HUA, JIE CHEN… - Breast cancer research …, 2012 - Springer